| |
Morning Scientific Symposium |
좌장: 강진형 (서울성모병원) |
| 08:50~09:30 |
A paradigm shift in ALK+NSCLC first-line treatment : clinical experience of ALUNBRIG® |
김태민 (서울대병원) |
| |
Plenary Session |
| |
Diagnosis & monitoring of lung cancer |
좌장: 김승준 (서울성모병원) |
| 09:30~09:50 |
Non-invasive biomarkers in lung cancer management |
박찬권 (여의도성모병원) |
| 09:50~10:10 |
Recent progress of lung cancer screening |
전경녀 (창원경상대병원) |
| 10:10~10:30 |
New WHO classification of lung tumors |
김루시아 (인하대병원) |
| |
Treatment of lung cancer |
좌장: 김상위 (서울아산병원) |
| 10:30~10:50 |
Surgical role in the era of perioperative immune checkpoint inhibitor |
김홍관 (삼성서울병원) |
| 10:50~11:10 |
New data of precision oncology practice from WCLC 2020 |
민영주 (울산대병원) |
| 11:10~11:30 |
Updated clinical trial data of immuno-oncology |
김혜련 (세브란스병원) |
| 11:30~11:40 |
Q&A |
| |
Scientific Symposium |
좌장: 이기형 (충북대병원) |
| 11:40~12:30 |
Beyond becoming a SOC in mNSCLC treatment, Pembrolizumab now opens a new era of More TOMORROWs |
이세훈 (삼성서울병원) |
| 12:30~13:00 |
Coffee Break |
| |
Room A |
Room B |
Room C |
| Parallel Session |
Multidisciplinary: Expanding indication of local therapy in lung cancer
좌장: 김연실 (서울성모병원)
|
|
Imaging and Screening
좌장: 김윤현 (전남대병원)
|
13:00~13:20
Radiofrequency ablation as lung cancer treatment
진공용 (전북대병원) |
|
13:00~13:25
Screening and early detection-lung cancer screening programs
임재광 (경북대병원) |
13:20~13:40
Radiotherapy in early stage and oligomers
임채홍 (고려대안산병원) |
13:25~13:50
Screening and early detection -risk modelling and artificial intelligence
남주강 (서울대병원) |
13:40~14:00
Limited surgery not limited to local disease
김현구 (고려대구로병원) |
13:50~14:15
Screening and early detection -radiological risk stratification
이종은 (전남대병원) |
| 14:00~14:20 Discussion |
14:15~14:20 Discussion |
Advanced NSCLC
좌장: 심병용 (성빈센트병원)
|
Pulmonology
좌장: 장승훈 (한림대성심병원)
|
Pathology & Biomarker Discovery
좌장: 이건국 (국립암센터)
|
14:20~14:50
Immunotherapy
박건욱 (계명대동산병원) |
14:20~14:40
Something new in Palliative and Supportive Care
여창동 (은평성모병원) |
14:20~14:40
The New WHO Classification of Lung Tumors
심효섭 (세브란스병원) |
14:40~15:00
Tumor Biology and Advances in Omics
이정은 (충남대병원) |
14:40~15:00
Getting All NSCLCs Genotyped: How Can We Get to 100%?
김태정 (여의도성모병원) |
14:50~15:20
New data from rare EGFR Alterations
이윤규 (강북삼성병원) |
15:00~15:20
Technological Advances in Diagnostics for Lung Cancer
김혜련 (원자력병원) |
15:00~15:20
Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma
최윤라 (삼성서울병원) |
| 15:20~15:30Discussion |
15:20~15:30 Discussion |
15:20~15:30 Discussion |
| 15:30~16:00 Coffee Break |
Thoracic malignancies
좌장: 이대호 (서울아산병원)
|
Thoracic Surgical Oncology
좌장: 강창현 (서울대병원)
|
Update in Radiation Oncology
좌장: 문성호 (국립암센터)
|
16:00~16:20
SCLC
임선민 (세브란스병원) |
16:00~16:20
- Therapeutic strategies for metachronous multiple primary lung cancer
- Prognostic factors and strategies for metachronous second primary lung cancer
조종호 (삼성서울병원) |
16:00~16:20
Radiotherapy for LA-NSCLC
송창훈 (분당서울대병원) |
16:20~16:45
Thymic Malignacy/Mesothelioma
박세훈 (삼성서울병원) |
16:20~16:40
- Characterization and classification of oligometastatic disease
- Surgery as a component of local consolidative therapy
이근동 (서울아산병원) |
16:20~16:40
New trends of radiotherapy in lung cancer
윤홍인 (세브란스병원) |
16:45~17:00
New challenges during COVID-19
강은주 (고려대구로병원) |
16:40~17:00
- Should role of surgery be re-evaluated in small cell lung cancer?
- Is there a role for surgery in stage I small cell lung cancer?
박성용 (세브란스병원) |
16:40~17:00
Radiotherapy for SCLC and other thoracic tumors (mesothelioma / thymoma)
곽유강 (인천성모병원) |
| 17:00~17:10 Discussion |
17:00~17:10 Discussion |
17:00~17:10 Discussion |